NWBO
NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics, Inc. (NWBO)
$25
About NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics, Inc. (NWBO)
Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.48
52 Week Low
$0.17
Market cap
371.3M
Dividend yield
0.00%
Volume
--
Avg. volume
3.4M
P/E ratio
-3.66
NORTHWEST BIOTHRPUTCS INC by Northwest Biotherapeutics, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.48
52 Week Low
$0.17
Market cap
371.3M
Dividend yield
0.00%
Volume
--
Avg. volume
3.4M
P/E ratio
-3.66